Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | LCK | P06239 | 1/20 | 0.44 |
| ▸ | FYN | P06241 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.44 |
| ▸ | RXRA | P19793 | 1/20 | 0.44 |
| ▸ | RXRB | P28702 | 1/20 | 0.44 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6744558 | 0.87 | ALDH1A1 (0.58) | ALDH1A1KMT2AHPGDPARP10POLB | |
| SCHEMBL1998149 | 0.86 | ALDH1A1 (0.53) | ALDH1A1KMT2ALCKFYNHPGD | |
| SCHEMBL711082 | 0.84 | ALDH1A1 (0.73) | ALDH1A1KMT2AHPGDPARP10RXRA | |
| SCHEMBL31412888 | 0.83 | ALDH1A1 (0.50) | ALDH1A1KMT2ALCKFYNHPGD | |
| SCHEMBL4081642 | 0.83 | ALDH1A1 (1.00) | ALDH1A1KMT2APARP10RXRARXRB | |
| SCHEMBL31485885 | 0.82 | TAS2R14 (0.49) | ALDH1A1KMT2ALCKFYNHPGD | |
| SCHEMBL227238 | 0.81 | SMN1; SMN2 (0.59) | ALDH1A1KMT2ALCKFYNHPGD | |
| SCHEMBL29053386 | 0.80 | ALDH1A1 (0.46) | ALDH1A1KMT2ALCKFYNHPGD | |
| SCHEMBL1316975 | 0.80 | ALDH1A1 (0.73) | ALDH1A1KMT2AHPGDMCL1HSD17B10 | |
| SCHEMBL28365983 | 0.80 | ALDH1A1 (0.73) | ALDH1A1KMT2AHPGDPARP10RXRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023160004-A1 | FUSED-RING COMPOUND HAVING ANALGESIC ACTIVITY, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 南京知和医药科技有限公司 | 2023-08-31 | — | — | WO | disclosed |
| EP-1701933-B1 | NOVEL COMPOUNDS | MITSUBISHI TANABE PHARMA CORP (JP) | 2008-09-03 | — | — | EP | disclosed |
| US-20070043113-A1 | Novel compounds | TANABE SEIYAKU CO., LTD. (JP) | 2007-02-22 | — | — | US | disclosed |
| CN-1898197-A | Novel compound | TANABE SEIYAKU CO (JP) | 2007-01-17 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070043113-A1 | Novel compounds | VCAM1, ICAM1, EPCAM | ALDH1A1 2146/4885KMT2A 3401/4885LCK 1655/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.